Correlation Between Madrigal Pharmaceuticals and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Pieris Pharmaceuticals.
Diversification Opportunities for Madrigal Pharmaceuticals and Pieris Pharmaceuticals
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Madrigal and Pieris is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Pieris Pharmaceuticals
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.75 times more return on investment than Pieris Pharmaceuticals. However, Madrigal Pharmaceuticals is 1.75 times more volatile than Pieris Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 6,524 in Madrigal Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 26,621 from holding Madrigal Pharmaceuticals or generate 408.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Pieris Pharmaceuticals |
Madrigal Pharmaceuticals and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Pieris Pharmaceuticals
The main advantage of trading using opposite Madrigal Pharmaceuticals and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |